Hypertension in heart transplant recipients: More than just cyclosporine

Journal of the American College of Cardiology

Volumn 41, Issue 3, 2003, Pages 433-434

  Eisen, Howard J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; CAPTOPRIL; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VASOPRESSIN;

DISEASE ASSOCIATION; DRUG ACTIVITY; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; NOTE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0037419762     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02821-8     Document Type: Editorial

References (15)

1. Emery RW, Miller LW, editors. Handbook of Cardiac Transplantation. Philadelphia, PA: Hanley and Belfus/Mosby, 1995.
2. Pflugfelder PW, Purves PD, McKenzie FN, Kostuk WJ. Cardiac dynamics during supine exercise in cyclosporine-treated orthotopic heart transplant recipients. Assessment by radionuclide angiography. J Am Coll Cardiol 1987;10:336-41.
3. Stevenson LW, Sietsma K, Tillisch JH, et al. Exercise capacity for survivors of cardiac or sustained medical therapy for heart failure. Circulation 1990;81:78-85.
4. Kobashigawa J, Leaf DA, Lee N, et al. A controlled trial of exercise rehabilitation after heart transplantation. N Engl J Med 1999;340:272-7.
5. Scherrer U, Vissing S, Morgan B, et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990;323:693-9.
6. Myers BD, Sibley R, Newton L. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988;33:590-600.
7. Ozdogan E, Banner N, Fitzgerald M, Musumeci F, Khaghani A, Yacoub M. Factors influencing the development of hypertension after heart transplantation. J Heart Lung Transplant 1990;9:548-53.
8. Braith RW, Mills RM, Wilcox CS, et al. Fluid homeostasis after heart transplantation: the role of cardiac denervation. J Heart Lung Transplant 1996;15:872-80.
9. Braith RW, Plunkett MB, Mills RM. Cardiac output responses during exercise in volume-expanded heart transplant recipients. Am J Cardiol 1998;81:1152-6.
10. Braith RW, Mills RM, Wilcox CS, Mitchell MJ, Hill JA, Wood CE. High-dose angiotensin-converting enzyme inhibition prevents fluid volume expansion in heart transplant recipients. J Am Coll Cardiol 2000;36:487-92.
11. Rickenbacher PR, Hunt SA. Long-term complications of transplantation. In: Emery RW, Miller LW, editors. Handbook of Cardiac Transplantation. Philadelphia, PA: Hanley and Belfus/Mosby, 1995:206-7.
12. Braith RW, Mills RM, Wilcox CS, Davis GL, Hill JA, Wood CE, High-dose angiotensin-converting enzyme inhibition restores body fluid homeostasis in heart transplant recipients. J Am Coll Cardiol 2003;41:426-32.
13. Braith RW, Wood CE, Limacher MC, et al. Abnormal neuroendocrine responses during exercise in heart-transplant recipients. Circulation 1992;86:1453-63.
14. Taylor DO, Barr ML, Radovancevic B. Randomized, ulticenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 1999;19:336-45.
15. Wilson RF, McGinn AL, Johnson TH, Christensen BV, Laxson DD. Sympathetic reinnervation after heart transplantation in humans. J Heart Lung Transplant 1992;11:S88-9.